Annual report pursuant to Section 13 and 15(d)

Statement of Changes in Stockholders' Equity

v3.24.1
Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   7,809,912    
Beginning balance at Dec. 31, 2021 $ 13,410 $ 1 $ 22,633 $ (9,224)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 1,120   1,120  
Stock issuance upon exercise of stock options (in shares) 38,806 38,806    
Stock issuance upon vesting and exercise of stock options $ 2   2  
Sale of Common Stock & warrants, net of fees and issuance costs (in shares)   136,025    
Sale of Common Stock & warrants, net of fees and issuance costs 804   804  
Stock issuance upon vesting of restricted stock units (in shares)   25,000    
Net loss $ (12,962)     (12,962)
Ending balance (in shares) at Dec. 31, 2022 8,009,743 8,009,743    
Ending balance at Dec. 31, 2022 $ 2,374 $ 1 24,559 (22,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense $ 3,208   3,208  
Stock issuance upon exercise of stock options (in shares) 180,072 180,072    
Stock issuance upon vesting and exercise of stock options $ 214   214  
Sale of Common Stock & warrants, net of fees and issuance costs (in shares)   17,872,955    
Sale of Common Stock & warrants, net of fees and issuance costs $ 24,764 $ 2 24,762  
Stock issuance upon vesting of restricted stock units (in shares)   258,970    
Stock Issuance upon exercise of warrants(in shares) 1,471 7,292    
Stock Issuance upon exercise of warrants $ 16   16  
Net loss $ (14,639)     (14,639)
Ending balance (in shares) at Dec. 31, 2023 26,329,032 26,329,032    
Ending balance at Dec. 31, 2023 $ 15,937 $ 3 $ 52,759 $ (36,825)